Trevor Ariza (Miami Heat) with an assist vs the Houston Rockets, 04/19/2021
Trevor Ariza (Miami Heat) with an assist vs the Houston Rockets, 04/19/2021
The Biden administration has approved the Vineyard Wind project, the first large offshore wind farm in the US.
When Oscar-winning director Barry Jenkins was considering adapting Colson Whitehead’s Pulitzer Prize-winning novel about the Underground Railroad into a limited series, he kept hearing the same thing: Impossible. It would be emotionally and mentally draining, Jenkins knew. Ultimately, Jenkins worked through the doubts.
The Axonius Cybersecurity Asset Management Platform is available through the DLT Solutions General Services Administration Multiple Award Schedules.
Oakville, Ontario--(Newsfile Corp. - May 12, 2021) - Cardiol Therapeutics Inc. (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, is pleased to announce the closing of its previously announced "bought deal" short form prospectus offering (the "Offering") of units of the Company ("Units") for aggregate gross proceeds of approximately $22 million.The Offering was completed by a syndicate of underwriters led ...
STRIDE, a boutique fitness franchise that is reinventing the definition of a runner through treadmill-based interval training, announced today it has signed a new agreement which gives the franchise partner the opportunity to bring seven new studios to the greater Denver area. Backed by boutique fitness curator Xponential Fitness, the treadmill studio franchise seeks to create a welcoming, supportive space where anybody can be a walker or runner.
Capital Health, a regional leader in providing progressive, quality patient care, has selected SwipeSense as its safety technology platform to prevent hospital-acquired infections (HAIs), and avoid preventable harm, such as patient falls, by ensuring consistent and safe care delivery. To tackle these issues, Capital Health will implement SwipeSense's Hand Hygiene and Nursing Insights applications system-wide in its two New Jersey hospitals.
The Leading Enterprise Architecture industry event brings together more than 1,000 IT Executives, CIOs and Enterprise Architects. It will showcase talks from world-renowned enterprise strategist Gregor Hohpe as well as insights from technology leaders from LEGO Group, J.M. Smucker Company, Itaú Unibanco, BCG Platinion, and McKinsey & Company.
Exadel (www.exadel.com), a software engineering company that delivers digital platforms, products, and applications, today announced they have opened a new office in Tbilisi, Georgia. This expansion comes on the heels of Exadel's recent acquisition by private equity investment firm, Sun Capital. With this new location in the Eastern European region, Exadel plans to expand its development capabilities by tapping into this area's burgeoning tech talent.
MALVERN, Pa., May 12, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) (the “Company”), a pharmaceutical company focused on developing and commercializing innovative products for acute care settings, today announced that Glass Lewis & Co. has recommended that Baudax Bio shareholders vote "FOR" Proposal 3, which seeks to amend the Company’s Amended and Restated Articles of Incorporation to increase the number of authorized shares of common stock from 100 million shares to 190 million shares. The Annual Meeting is expected to resume with respect to Proposal 3 on June 3, 2021 at 10:00 a.m. ET and will continue to be held virtually at www.virtualshareholdermeeting.com/BXRX2021. Glass Lewis is widely recognized as one of the leading independent proxy voting and corporate governance advisory firms, and its recommendations are relied upon by thousands of major institutional investment firms, mutual funds and other fiduciaries throughout the United States. In response to the favorable recommendation, Gerri Henwood, President and CEO of Baudax Bio said, “We are pleased that Glass Lewis, a highly regarded, independent, leading proxy advisory firm understands the importance of increasing the number of authorized shares to a level that allows us to achieve our corporate objectives and attract a broader and more diverse shareholder base.” Baudax shareholders are urged to vote as Glass Lewis recommend by voting "FOR" the proposed increase in authorized shares. Shareholders with questions may call Okapi Partners LLC at (855) 208-8902 or by email at email@example.com. How to Vote If you are a shareholder of record at the close of business on March 1, 2021, you can vote your shares in one of two ways: either by proxy or in person at the special meeting. If you chose to submit a proxy, you may do so by telephone, via the internet or by mail. Please follow the instructions on the proxy card you have received. If you hold shares of Baudax Bio common stock in multiple accounts, you should vote your shares as described in each set of proxy materials you receive. Baudax Bio highly recommends shareholders vote electronically or by phone without delay. Please have your proxy card with you while voting. If you chose to vote via the Internet or phone, you do not have to return the proxy card. Shareholders who have already submitted a proxy do not need to vote again for the reconvened Annual Meeting, as the proxies submitted will remain valid. Shareholders who have already submitted proxies and want to change their vote with respect to Proposal 3 can update their vote in the manner set forth in the Proxy Statement. Your vote will be recorded at the Annual Meeting in accordance with your most recently submitted proxy. For shareholders who still need assistance voting their shares, or have questions regarding the special meeting, please contact Baudax Bio’s proxy solicitation firm, Okapi Partners LLC, either by telephone: (855) 208-8902 or by email: firstname.lastname@example.org. About Baudax Bio Baudax Bio is a pharmaceutical company focused on developing and commercializing innovative products for acute care settings. The launch of Baudax Bio’s first commercial product ANJESO® began in mid-2020. ANJESO is the first and only 24-hour, intravenous (IV) COX-2 preferential non-steroidal anti-inflammatory (NSAID) for the management of moderate to severe pain, which can be administered alone or in combination with other non-NSAID analgesics. It has successfully completed three Phase III clinical trials, including two pivotal efficacy trials, a large double-blind Phase III safety trial and a Phase IIIb program evaluating ANJESO and its health economic impact in specific surgical settings. In addition to ANJESO, Baudax Bio has a pipeline of other innovative pharmaceutical assets including two novel neuromuscular blocking agents (NMBAs) and a proprietary chemical reversal agent specific to these NMBAs which is currently in preclinical studies. For more information, please visit www.baudaxbio.com. Forward Looking Statements This press release contains forward-looking statements that involve risks and uncertainties. Such forward-looking statements reflect Baudax Bio’s expectations about its future performance and opportunities that involve substantial risks and uncertainties. When used herein, the words “anticipate,” “believe,” “estimate,” “may,” “upcoming,” “plan,” “target,” “goal”, “intend” and “expect” and similar expressions, as they relate to Baudax Bio or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information available to Baudax Bio as of the date of publication on this internet site and are subject to a number of risks, uncertainties, and other factors that could cause Baudax Bio’s performance to differ materially from those expressed in, or implied by, these forward-looking statements. Baudax Bio assumes no obligation to update any such forward-looking statements. These forward-looking statements should be considered together with the risks and uncertainties that may affect our business and future results included in our filings with the Securities and Exchange Commission at www.sec.gov. These forward-looking statements are based on information currently available to us, and we assume no obligation to update any forward-looking statements except as required by applicable law. These forward looking statements should be considered together with the risks and uncertainties that may affect Baudax Bio’s business and future results included in Baudax Bio’s filings with the Securities and Exchange Commission at www.sec.gov. CONTACT: Investor Relations Contact:Argot PartnersSam Martin / Claudia Styslinger(212) email@example.com Media Contact:Argot PartnersDavid Rosen(212) firstname.lastname@example.org
Orbbec, a leading global 3D camera manufacturer, today announced a collaboration with Microsoft to develop new products and technologies in the fast-expanding 3D imaging category. Encompassing Microsoft's market-leading 3D sensor technology and Orbbec's camera design know-how, manufacturing capabilities, and unique embedded computing technology, the company will introduce new cameras in 2022, to satisfy the burgeoning demand for 3D sensing technology. Connecting this sensor to the Azure cloud platform will unleash computer vision and AI developers to build solutions for logistics, robotics, retail, healthcare, and fitness markets.
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to developing innovative treatments for nerve damage and neurodegenerative diseases, announced that it has closed its previously announced overnight, "best efforts" marketed public offering (the "Offering") of units (the "Units"). Pursuant to the Offering, NervGen issued an aggregate of 3,250,000 units of the Company at a price of ...
Technomic has released the beverage category sizing report exploring how COVID-19 impacted foodservice beverages. This report is a deliverable of the Away-From-Home Beverage Navigator program, which offers a comprehensive assessment of both hot and cold beverage categories, including market sizing, historical tracking, predicted growth, consumer insights, operator responses, major trends and market dynamics.
Styra, Inc., the founder of Open Policy Agent (OPA) and leader in cloud-native authorization, has been named to Inc. magazine’s annual list of the Best Workplaces for 2021. Hitting newsstands May 18 in the May/June 2021 issue, and as part of a prominent Inc.com feature, the list is the result of a wide-ranging and comprehensive measurement of American companies that have created exceptional workplaces and company culture whether teams are operating in person or remotely.
Nominations are open for the second annual Guest Room attendant (GRA) Excellence Award, acknowledging the contributions of GRAs at hotels across the United States. Sponsored by UMF Corporation, the award takes on even more importance in a year that upended the hospitality industry. GRAs serve as the first line of defense in cleaning and disinfecting guest rooms and common areas in hotels, and their role has been crucial as the world battles the pandemic. Nominations are open through July, 31, 2021.
KEY FINDINGS The global cyber situational awareness market is estimated to record a CAGR of 17. 78% during the forecast period, 2021-2028. The major growth drivers include wireless technology implementation, frequent cyberattacks, cloud technology adoption in multiple sectors, and business data digitization.New York, May 12, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "GLOBAL CYBER SITUATIONAL AWARENESS MARKET FORECAST 2021-2028" - https://www.reportlinker.com/p06071675/?utm_source=GNW MARKET INSIGHTSDigital technologies have made their place in an everyday routine, right from simple mobile devices to complex software and electronics.Edge computing has gained traction in the commercial sector since it minimizes the overall latency in acquiring data from respective servers.It is also projected to increase the demand for several parallel technologies like the Internet of Things (IoT) and cloud computing.The rise of digital technologies has also increased the associated risks, widening the gap of losses.According to McAfee statistics, cybercrime incidents incurred a loss of $1 trillion in 2019.In the same year, the Interstate Technology and Regulatory Council (ITRC) disclosed that hacking was the prominent method used to breach data.This includes intrusion methods like skimming, phishing, and ransomware & malware.Thus, with emerging technologies, cyber situational awareness is on the rise, contributing to market growth. However, budget limitations and regulation variation hinder the market growth.REGIONAL INSIGHTSThe growth assessment of the global cyber situational awareness market includes the analysis of North America, Asia-Pacific, Europe, and Rest of World. With companies in the Asia-Pacific increasingly adopting managed security services, the region is set to record the highest CAGR by 2028.COMPETITIVE INSIGHTSThe competitive rivalry in the market is dictated by increasing product penetration levels, high level of competition, and moderate to high product differentiation. IBM Corporation, SAS Institute, Honeywell International, Palo Alto Networks Inc, etc., are among the market’s key players.Our report offerings include:• Explore key findings of the overall market• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions• Market Segmentation cater to a thorough assessment of key segments with their market estimations• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developmentsCompanies mentioned1. CYWARE2. DARKTRACE3. FIREMON LLC4. HONEYWELL INTERNATIONAL5. IBM CORPORATION6. MARKLOGIC CORPORATION7. PALANTIR TECHNOLOGIES INC8. PALO ALTO NETWORKS INC9. SAS INSTITUTE10. VERINT SYSTEMS INCRead the full report: https://www.reportlinker.com/p06071675/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
With its customers already reaching new heights in terms of pipeline revenue, Drift, the world's leading revenue acceleration platform, today announced the addition of two talented individuals to lead its customer success organization: Bart Hammond as Chief Customer Officer, and Ryan Schultz as Vice President of Customer Success.
Dion Lisle of advisory firm FACERE25 is partnering with Michael Cavallaro and Carlton Jenkins of investment banking firm MJC Partners to launch Forty Grand whose singular mission is to drive value for community banks by delivering Fintech focused digital innovation. The three founding partners each bring a unique perspective but share the same vision for what community banks need to modernize and deliver digital experiences for their customers.
Shares of Arthur J. Gallagher & Co. fell 0.7% in premarket trading Wednesday, after the insurance brokerage and consulting services company announced a public offering of 9 million shares of common stock. At Tuesday's stock closing price of $148.46, the offering, which represents about 4.6% of the shares outstanding, would be valued at $1.34 billion. The company plans to use the proceeds from the offering to fund a part of the deal announced earlier in which it buys certain Willis Towers Watson PLC's assets for $3.57 billion. Willis Towers and merger partner Aon PLC said the sale of the assets resolves questions raised by the European Commission and other jurisdictions related to the companies' merger, which was originally announced in March 2020. Aon's stock edged up 0.1% and Willis Tower shares slipped 0.1%, while futures for the S&P 500 dropped 0.7%.
Specialty-specific healthcare information technology leader Modernizing Medicine® today announced it has released the latest version of ophthalmic Image Management to help ophthalmologists save time and deliver efficiency associated with diagnostic imaging workflows.
Marchex (NASDAQ: MCHX), a leading conversational analytics and solutions company that connects the voice of the customer to your business, today announced the release of its newest artificial intelligence-powered solution, developed specifically for automotive dealers. Marchex Engage for Automotive is an innovative conversation intelligence application that enables automotive sales teams to deliver better buying experiences and improve sales outcomes.